Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
| (1) |
|
Registration Statement (Form S-8 No. 333-56933) pertaining to the OncoGenex
Pharmaceuticals, Inc. Incentive Stock Option, Nonqualified Stock Option and Restricted Stock
Purchase Plan-1991; |
| (2) |
|
Registration Statement (Form S-8 No. 333-87897) pertaining to the OncoGenex
Pharmaceuticals, Inc. Incentive Stock Option, Nonqualified Stock Option and Restricted Stock
Purchase Plan-1991, 1995 Stock Option Plan for Directors, Employee Stock Purchase Plan, and
1999 Nonqualified Stock Incentive Plan; |
| (3) |
|
Registration Statement (Form S-8 No. 333-49892) pertaining to the OncoGenex
Pharmaceuticals, Inc. 1999 Nonqualified Stock Incentive Plan and 2000 Stock Incentive Plan; |
| (4) |
|
Registration Statement (Form S-8 No. 333-56704) pertaining to the OncoGenex
Pharmaceuticals, Inc. 2000 Stock Incentive Plan and 401(k) Profit Sharing Plan and Trust; |
| (5) |
|
Registration Statement (Form S-8 No. 333-135697) pertaining to the OncoGenex
Pharmaceuticals, Inc. 2000 Stock Incentive Plan; |
| (6) |
|
Registration Statement (Form S-8 No. 333-144552) pertaining to the OncoGenex
Pharmaceuticals, Inc., #2007 Performance Incentive Plan and 401(k) Profit Sharing Plan and
Trust; |
| (7) |
|
Registration Statement (Form S-8 No. 333-153206) pertaining to the OncoGenex
Technologies, Inc. Amended and Restated Stock Option Plan; |
| (8) |
|
Registration Statement (Form S-3 No. 333-128030) pertaining to the registration for resale of
shares of common stock of OncoGenex Pharmaceuticals, Inc. and in the related Prospectus; |
| (9) |
|
Registration Statement (Form S-3 No. 333-160251) pertaining to the registration of shares of
common stock of OncoGenex Pharmaceuticals, Inc. and in the related Prospectus; |
of our report dated March 8, 2010, with respect to the consolidated financial statements of
OncoGenex Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended
December 31, 2009.
Vancouver, Canada
March 8, 2010
